Roberto Cobos-Corchado

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A RAC1 SUMOylation switch governs breast cancer metastasis.

A RAC1 SUMOylation switch governs breast cancer metastasis.

Journal: Signal transduction and targeted therapy

Published: November 05, 2025

Cross-Species and Tissue-Agnostic Prediction of Human Cancer Treatment Response using AI-Powered Cellular Morphometric Biomarkers from a Genetically Diverse Erbb2 Mouse Model.

Cross-Species and Tissue-Agnostic Prediction of Human Cancer Treatment Response using AI-Powered Cellular Morphometric Biomarkers from a Genetically Diverse Erbb2 Mouse Model.

Journal: medRxiv : the preprint server for health sciences

Published: September 26, 2025

Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies.

Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies.

Journal: International journal of molecular sciences

Published: February 05, 2025

A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice.

A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice.

Journal: EBioMedicine

Published: March 05, 2024

Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.

Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.

Journal: Research square

Published: February 26, 2024

NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence.

NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence.

Journal: Research square

Published: October 27, 2023

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.

Journal: Clinical and translational medicine

Published: October 21, 2023

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

Journal: Cells

Published: April 17, 2023

Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk.

Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk.

Journal: bioRxiv : the preprint server for biology

Published: January 30, 2023

Evolutionary Origins of Metabolic Reprogramming in Cancer.

Evolutionary Origins of Metabolic Reprogramming in Cancer.

Journal: International journal of molecular sciences

Published: August 24, 2022

TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study.

TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 24, 2022

Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer.

Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer.

Journal: Cancers

Published: November 28, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026